Antitumor Activity of Protons and Molecular Hydrogen: Underlying Mechanisms

被引:7
|
作者
Rochette, Luc [1 ]
Zeller, Marianne [1 ]
Cottin, Yves [1 ,2 ]
Vergely, Catherine [1 ]
机构
[1] Univ Bourgogne Franche Comte, Fac Hlth Sci, PEC2 EA7460, 7 Bd Jeanne Arc, F-21000 Dijon, France
[2] Univ Hosp Dijon, Dept Cardiol, F-21000 Dijon, France
关键词
molecular hydrogen; antioxidant; cancer;
D O I
10.3390/cancers13040893
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Protons (H+) and molecular hydrogen (H-2) in the cell are critical in a wide variety of processes. New cancer treatment uses H-2, a biologically inactive gas. H-2 can rapidly penetrate cell membranes and reach subcellular components to protect nuclear DNA and mitochondria. H-2 reduces oxidative stress, exerts anti-inflammatory effects, and acts as a modulator of apoptosis. Exogenous H-2 is a protective therapy that can be used in cancer. Cyclotrons and synchrotrons are currently used to produce protons. Proton beam radiotherapy (PBT) offers great promise for the treatment of a wide variety of cancers. H-2 and different types of H-2 donors may represent a novel therapeutic strategy in cancer treatment. Understanding the structure and dynamics of the various hydrogen forms has been a subject of numerous studies. Protons (H+) and molecular hydrogen (H-2) in the cell are critical in a wide variety of processes. A new cancer treatment uses H-2, a biologically inactive gas. Due to its small molecular weight, H-2 can rapidly penetrate cell membranes and reach subcellular components to protect nuclear DNA and mitochondria. H-2 reduces oxidative stress, exerts anti-inflammatory effects, and acts as a modulator of apoptosis. Exogenous H-2, administered by inhalation, drinking H-2-rich water, or injecting H-2-rich saline solution, is a protective therapy that can be used in multiple diseases, including cancer. In particle therapy, cyclotrons and synchrotrons are the accelerators currently used to produce protons. Proton beam radiotherapy (PBT) offers great promise for the treatment of a wide variety of cancers due to the sharp decrease in the dose of radiation at a defined point. In these conditions, H-2 and different types of H-2 donors may represent a novel therapeutic strategy in cancer treatment.
引用
收藏
页码:1 / 11
页数:10
相关论文
共 50 条
  • [31] Molecular Mechanisms Underlying Differentiation of Thymocytes
    E. M. Kuklina
    Russian Journal of Developmental Biology, 2003, 34 (5) : 285 - 299
  • [32] DISSOCIATION OF HYDROGEN MOLECULAR IONS BY FAST PROTONS
    BATES, DR
    HOLT, AR
    PROCEEDINGS OF THE PHYSICAL SOCIETY OF LONDON, 1965, 85 (546P): : 691 - &
  • [33] Molecular Mechanisms Underlying Vascular Development
    Jung, Jae-Hoon
    Kim, Sang-Gyu
    Seo, Pil Joon
    Park, Chung-Mo
    ADVANCES IN BOTANICAL RESEARCH, VOL 48, 2008, 48 : 1 - 68
  • [34] Endothermy in birds: underlying molecular mechanisms
    Walter, Isabel
    Seebacher, Frank
    JOURNAL OF EXPERIMENTAL BIOLOGY, 2009, 212 (15): : 2328 - 2336
  • [35] Molecular Mechanisms Underlying Neurotransmitter Release
    Rizo, Josep
    ANNUAL REVIEW OF BIOPHYSICS, 2022, 51 : 377 - 408
  • [36] Molecular mechanisms underlying the emergence of neural
    Ghosh, Anirvan
    NEUROSCIENCE RESEARCH, 2010, 68 : E12 - E12
  • [37] Molecular mechanisms underlying oxygen reception
    Kolesnikova E.É.
    Neurophysiology, 2004, 36 (4) : 293 - 309
  • [38] Molecular Mechanisms Underlying Bacterial Persisters
    Maisonneuve, Etienne
    Gerdes, Kenn
    CELL, 2014, 157 (03) : 539 - 548
  • [39] Molecular mechanisms underlying the pathogenesis of steatosis
    Hoek, Jan B.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2006, 30 (09) : 66A - 66A
  • [40] The molecular mechanisms underlying mussel adhesion
    Li, Yiran
    Cao, Yi
    NANOSCALE ADVANCES, 2019, 1 (11): : 4246 - 4257